SS-31, also known as Elamipretide or Bendavia, is a mitochondria-targeted tetrapeptide developed for scientific research on mitochondrial structure and function. As a mitochondria-targeted peptide, SS-31 has been widely investigated in preclinical studies involving mitochondrial membrane integrity, oxidative stress, cellular energy metabolism, and mitochondrial dysfunction.
SS-31 is a short, mitochondria-targeted peptide designed to interact with cardiolipin, a phospholipid predominantly located in the inner mitochondrial membrane. Research indicates that this interaction may influence mitochondrial membrane organization and mitochondrial bioenergetic processes.
Due to its unique mitochondrial-targeting properties, SS-31 has attracted considerable interest in studies related to cellular metabolism, oxidative stress, aging research, cardiovascular biology, neuromuscular research, and mitochondrial-related cellular models.
SS-31 is characterized by its ability to selectively associate with mitochondrial membranes and interact with cardiolipin. This property makes it a useful research tool for investigating the relationship between mitochondrial membrane structure, electron transport, oxidative stress, and cellular energy production.
Product Name: SS-31 / Elamipretide
SS-31 is supplied for laboratory and research purposes only. It is not intended for human or veterinary use, diagnosis, treatment, prevention, or cure of any disease. Research applications should be conducted by qualified professionals in accordance with applicable laboratory and regulatory requirements.
SS-31 (Elamipretide)
Product Overview
Key Research Areas
Mechanism of Research Interest
Product Features
Alternative Name: Bendavia
Peptide Type: Mitochondria-targeted tetrapeptide
Research Focus: Mitochondrial function and cellular bioenergetics
Application: For Research Use Only (RUO)
Research Disclaimer
RayShine Biotech